Hepatitis B reactivation prophylaxis in immune-suppressed patients

In their letter “Hepatitis B virus-related liver disease in isolated anti-hepatitis b-core positive lymphoma patients receiving chemo- or chemo-immune therapy” Targhetta et al. conclude that in the case of occult HBV infection in lymphoma patients close monitoring is mandatory, whereas there is